|
US4115577A
(en)
*
|
1972-06-19 |
1978-09-19 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzheterocycles
|
|
US4183936A
(en)
*
|
1972-06-19 |
1980-01-15 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzheterocycles
|
|
US4013652A
(en)
*
|
1972-06-19 |
1977-03-22 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzoxazine
|
|
FR2428035A1
(fr)
*
|
1978-06-05 |
1980-01-04 |
Sankyo Co |
Derives de benzothiazocine et de benzothiazonine, et leur application therapeutique
|
|
US4219550A
(en)
*
|
1978-11-09 |
1980-08-26 |
E. I. Du Pont De Nemours And Company |
Cis- and trans- octahydropyridopyrrolobenzheterocycles
|
|
EP0357417A1
(fr)
*
|
1988-09-01 |
1990-03-07 |
Glaxo Group Limited |
Dérivés de lactames
|
|
US5223625A
(en)
*
|
1988-12-22 |
1993-06-29 |
Duphar International Research B.V. |
Annelated indolo [3,2,-C]lactams
|
|
EP0380155A1
(fr)
*
|
1989-01-19 |
1990-08-01 |
Duphar International Research B.V |
Dérivés de 1,2,3,4-tétrahydro-bêta-carboline, 8,9-annelés
|
|
WO2000077001A1
(fr)
|
1999-06-15 |
2000-12-21 |
Du Pont Pharmaceuticals Company |
Gamma-carbolines fusionnees a heterocycles substitues
|
|
US7071186B2
(en)
|
1999-06-15 |
2006-07-04 |
Bristol-Myers Squibb Pharma Co. |
Substituted heterocycle fused gamma-carbolines
|
|
US6713471B1
(en)
|
1999-06-15 |
2004-03-30 |
Bristol-Myers Squibb Pharma Company |
Substituted heterocycle fused gamma-carbolines
|
|
RU2003121304A
(ru)
*
|
2000-12-20 |
2005-01-27 |
Бристол-Маерс Сквибб Компани (Us) |
Замещенные пиридоиндолы в качестве агонистов и антагонистов серотонина
|
|
MXPA03005355A
(es)
|
2000-12-20 |
2004-05-27 |
Bristol Myers Squibb Co |
Pirroloquinolinas y piridoquinolinas sustituidas como agonistas y antagonistas de serotonina.
|
|
US6849619B2
(en)
*
|
2000-12-20 |
2005-02-01 |
Bristol-Myers Squibb Company |
Substituted pyridoindoles as serotonin agonists and antagonists
|
|
HUP0303513A3
(en)
|
2000-12-20 |
2005-12-28 |
Bristol Myers Squibb Pharma Co |
Substituted pyrazinoquinoxaline derivatives as serotonin receptor agonists and antagonists, their use and pharmaceutical compositions containing them
|
|
BR0212676A
(pt)
|
2001-09-21 |
2006-05-23 |
Upjohn Co |
compostos terapêuticos ligantes de 5-ht, composições farmacêuticas compreendendo tais compostos e seus usos
|
|
WO2004056324A2
(fr)
*
|
2002-12-19 |
2004-07-08 |
Bristol-Myers Squibb Company |
Gamma-carbolines tricycliques substituees utilisees comme agonistes et antagonistes du recepteur de la serotonine
|
|
MX394214B
(es)
*
|
2007-03-12 |
2025-03-24 |
Intra Cellular Therapies Inc |
Sintesis de gamma-carbolinas fusionadas con heterociclo substituido.
|
|
WO2011044134A1
(fr)
|
2009-10-05 |
2011-04-14 |
Albany Molecular Research, Inc. |
Dérivés d'épiminocycloalkyl(b)indole utilisés en tant que modulateurs du récepteur de la sérotonine de sous-type 6 (5-ht6) et leurs utilisations
|
|
AU2012207335A1
(en)
|
2011-01-19 |
2013-07-25 |
Albany Molecular Research, Inc. |
Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
|
|
US9428506B2
(en)
|
2012-04-14 |
2016-08-30 |
Intra-Cellular Therapies, Inc. |
Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disorders
|
|
WO2014145192A1
(fr)
|
2013-03-15 |
2014-09-18 |
Intra-Cellular Therapies, Inc. |
Composés organiques
|
|
KR102967223B1
(ko)
|
2013-12-03 |
2026-05-19 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
신규한 방법
|
|
US9745300B2
(en)
|
2014-04-04 |
2017-08-29 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
KR20220054908A
(ko)
|
2014-04-04 |
2022-05-03 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
유기 화합물
|
|
RU2743513C2
(ru)
|
2016-01-26 |
2021-02-19 |
Интра-Селлулар Терапиз, Инк. |
Органические соединения
|
|
IL281050B2
(en)
|
2016-03-25 |
2023-04-01 |
Intra Cellular Therapies Inc |
A controlled or delayed release pharmaceutical preparation containing a deuterated compound
|
|
WO2017172811A1
(fr)
|
2016-03-28 |
2017-10-05 |
Intra-Cellular Therapies, Inc. |
Nouveaux co-cristaux
|
|
US10682354B2
(en)
|
2016-03-28 |
2020-06-16 |
Intra-Cellular Therapies, Inc. |
Compositions and methods
|
|
WO2017172784A1
(fr)
|
2016-03-28 |
2017-10-05 |
Intra-Cellular Therapies, Inc. |
Nouveaux sels et cristaux
|
|
JP7013454B2
(ja)
|
2016-10-12 |
2022-02-15 |
イントラ-セルラー・セラピーズ・インコーポレイテッド |
アモルファス固体分散体
|
|
WO2018126140A1
(fr)
|
2016-12-29 |
2018-07-05 |
Intra-Cellular Therapies, Inc. |
Composés organiques
|
|
EP3562484B1
(fr)
|
2016-12-29 |
2021-08-25 |
Intra-Cellular Therapies, Inc. |
Dérivés de pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline utiles dans les traitements de troubles du snc
|
|
EP3600325A4
(fr)
|
2017-03-24 |
2021-01-06 |
Intra-Cellular Therapies, Inc. |
Nouvelles compositions et méthodes
|
|
WO2019023062A1
(fr)
|
2017-07-26 |
2019-01-31 |
Intra-Cellular Therapies, Inc. |
Composés organiques
|
|
JP7224333B2
(ja)
|
2017-07-26 |
2023-02-17 |
イントラ-セルラー・セラピーズ・インコーポレイテッド |
有機化合物
|
|
AU2019240226B2
(en)
|
2018-03-23 |
2024-11-28 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
SMT202600133T1
(it)
|
2018-03-23 |
2026-05-12 |
Intra Cellular Therapies Inc |
Composti organici
|
|
BR112020024885A2
(pt)
|
2018-06-06 |
2021-03-09 |
Intra-Cellular Therapies, Inc. |
Novos sais e cristais
|
|
EP3801527B1
(fr)
|
2018-06-08 |
2025-02-19 |
Intra-Cellular Therapies, Inc. |
Gamma-carbolines fusionnées pour le traitement aigu de l'anxiété ou de la dépression
|
|
RS67906B1
(sr)
|
2018-06-11 |
2026-04-30 |
Intra Cellular Therapies Inc |
Sinteza supstituisanih heterociklično fuzionisanih gama-karbolina
|
|
US12144808B2
(en)
|
2018-08-29 |
2024-11-19 |
Intra-Cellular Therapies, Inc. |
Compositions and methods
|
|
AU2019328528B2
(en)
|
2018-08-31 |
2025-01-23 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
|
WO2020047408A1
(fr)
|
2018-08-31 |
2020-03-05 |
Intra-Cellular Therapies, Inc. |
Nouvelles méthodes
|
|
EP4134101A1
(fr)
|
2019-07-07 |
2023-02-15 |
Intra-Cellular Therapies, Inc. |
Lumateperone deuteree pour le traitement du trouble bipolaire ii
|
|
US12414948B2
(en)
|
2022-05-18 |
2025-09-16 |
Intra-Cellular Therapies, Inc. |
Methods
|